Phase A — Understand the business
Lens 1 · Company Overview
Richtech Robotics designs, manufactures, and deploys "embodied AI" service and industrial robots, increasingly under a Robots-as-a-Service (RaaS) subscription model. Founded 2016 as "Richtech Creative Displays LLC," converted to a Nevada corp in 2022, IPO'd on Nasdaq 2023-11-21 under ticker RR.
Product lines (reorganized in Q4 FY25 into three pillars):
- Commercial: Matradee (restaurant server/busser AMR), ADAM (dual-arm AI bartender/barista), Scorpion (smaller/cheaper ADAM variant).
- Industrial: Titan (heavy-duty delivery AMR, "best-selling" line), DUST-E S/MX (autonomous floor scrubbers), and Dex — a wheeled-base "humanoid" on NVIDIA Jetson Thor, unveiled at GTC, "expected to be officially launched in early 2026."
- Data Services: sells real-world robot-operation datasets (joint trajectories, gripper manipulations) for "frontier embodied AI training"; the former AI Cloud Platform folded in here.
- Discontinued in FY25: Skylark and Medbot lines.
Stated mission: become a robotics "Super-Operator" running >100,000 connected robots. Reality: "several hundred active deployments in the U.S." / "over 400 robots in the field".
Customers / contract structure: Transitioning from outright hardware sales (point-in-time ASC 606 recognition) to RaaS (recognized over the lease term). "RaaS agreements constituted the majority of signed contracts" in FY25. Marquee names cited: an MSA with a "top-5 U.S. dealership group" (Titan parts delivery in service departments); a plan announced 2024-10-17 for "20 robotic restaurant locations within Walmart stores" — of which only two are actually in operation as of the 10-K. Owns hospitality subsidiary Alphamax Management (the "Clouffee & Tea" robotic café franchise) which did ~$602K of non-robotics restaurant revenue in FY25.
Customer concentration: customers.csv empty; the filing does not quantify per-customer share, but with ~$5M revenue spread across "several hundred" deployments, any single enterprise MSA is material. The legal action in Item 3 (a NY breach-of-contract/fraud suit seeking >$600K, 2025-06-02) is itself ~12% of annual revenue — a tell of how small the base is.
Lens 2 · Supply Chain
Upstream → RR → end customer, named where disclosed:
- Compute / silicon (chokepoint): NVIDIA — Jetson Thor module powers Dex; Isaac Sim used for training. This is the single most strategically important — and most marketing-leveraged — input. RR is a buyer of NVIDIA, not a partner of consequence.
- Contract manufacturing (chokepoint + geopolitical): "Some of the products are currently assembled by suppliers in China". Explicit tariff / trade-restriction / shipping exposure called out repeatedly in the risk factors. Single largest hard-cost and supply risk.
- In-house: final design/engineering and some assembly; AI model training on proprietary data.
- Downstream: direct deployment + maintenance across continental US, Canada, Mexico, Puerto Rico, Hawaii, plus Australia; some international via planned (not executed) JV/distributor deals.
Single-source dependency: NVIDIA for high-end compute; Chinese CMs for hardware assembly. Neither is contractually de-risked in the filing. The chain is thin and offshore-anchored — ironic for a company whose pitch is "AI data anchored in the United States."
Lens 3 · Competitive Advantages (moats)
RR's self-described moats: first-mover brand in U.S. service robotics, deployment/market knowledge, breadth of product line, RaaS data flywheel, and proprietary training data.
Honest assessment — the moat is shallow-to-nonexistent:
- The company itself admits "the commercial service robotics market has no clearly defined market leader" — i.e., it is not the leader, just early.
- Named competitors out-position it on the axes that matter: Bear Robotics (Servi, also RaaS, well-funded — SoftBank-backed) and Pudu (cheaper, China) on Matradee/Titan; Avidbots ("over $10,000 less" on the equivalent scrubber, per RR's own filing) and Tennant (NYSE: TNC, a real industrial-cleaning incumbent) on DUST-E; Miso and Cafe X on ADAM; and Tesla (Optimus) + Figure AI on Dex. RR concedes Avidbots undercuts it on price — the opposite of pricing power.
- "Inter-operability lock-in" is asserted but unproven at a few-hundred-unit scale.
- The "data moat" is a narrative: there is no evidence of a foundation-model customer paying at scale, and the Data Services pillar generated negligible disclosed revenue.
Bargaining power: Weak both ways. RR needs NVIDIA and Chinese CMs more than they need RR (it is a trivially small buyer); and against enterprise customers, RR is the one giving "day-one ROI" RaaS terms and free pilots to win business. No durable moat. The only real asset is the balance-sheet cash, which is not a competitive advantage — it is dry powder being spent on opex.
Lens 4 · Segments
No GAAP reportable-segment breakout in the filing (the company runs as a single segment; the three "pillars" are managerial, not reported). The only segmentation disclosed is revenue by stream:
| Revenue stream (FY, $000) | FY2025 | FY2024 | Δ |
|---|
| Product Sale (outright hardware) | 2,309 | 1,357 | +952 |
| Leasing / Service / Rental | 1,429 | 2,624 | (1,195) |
| RaaS | 692 | — | +692 |
| Other (incl. Alphamax/Clouffee) | 615 | 259 | +356 |
| Total revenue, net | 5,045 | 4,240 | +805 |
Read: The headline "+19% revenue growth" is low-quality. It was driven by one-time legacy hardware orders (Product +$952K, which management itself calls "occasional, non-recurring… does not reflect a shift in our long-term revenue strategy"), while the recurring Leasing/Service/Rental stream fell by $1.2M (partly a reclassification into the new RaaS line). The recurring base is not yet compounding — it is being reshuffled between line items. Geographically the business is ~entirely U.S./North America. The Q1-FY26 print (below) confirms the "growth" did not stick — revenue went negative YoY.
Phase B — Measure performance
Lens 5 · Earnings Result
Most recent print — Q1 FY26, three months ended 2025-12-31:
| ($000) | Q1 FY26 | Q1 FY25 | Δ YoY |
|---|
| Revenue, net | 1,147 | 1,257 | −8.8% |
| Cost of revenue | 547 | 123 | +345% |
| Gross profit | 600 | 1,134 | −47% |
| Gross margin | 52.3% | 90.2% | −38 pts |
| R&D | 448 | 484 | −7% |
| Sales & marketing | 188 | 245 | −23% |
| G&A | 11,773 | 4,303 | +174% |
| Operating loss | (11,809) | (3,898) | −203% |
| Investment income | 3,401 | 333 | +921% |
| Net loss | (8,402) | (3,548) | −137% |
| EPS (basic/diluted) | (0.04) | (0.04) | flat |
| Wtd-avg shares (M) | 197.7 | 95.8 | +106% |
The damning lines, in order of importance:
- Revenue went DOWN (−8.8% YoY). A company valued at ~90x sales on a "physical-AI growth" story shrank its top line. Full-year FY23→FY25 revenue fell ~42% from the ~$8.76M peak to $5.05M.
- Investment income ($3.4M) dwarfs product gross profit ($0.6M). RR makes ~5.7x more money from interest on its cash hoard than from selling robots. This is a money-market fund cosplaying as a robotics company.
- G&A of $11.8M is ~10x revenue. The reported net loss is heavily a function of non-cash stock-based compensation (~$8.3M of the ~$8.4M loss per web summaries) — i.e., the "adjusted" loss is small, but that's because the real cost is being paid in dilution, not cash. Shareholders fund the burn by being diluted, not by a P&L line.
- Share count doubled YoY (197.7M vs 95.8M weighted-avg) — the single clearest fact about this equity.
Balance-sheet flags:
- Cash & equivalents $271.8M at 2025-12-31 (up from $193.6M at FYE), plus short-term investments — funded almost entirely by ATM equity issuance, not operations.
- FY25 operating cash burn −$9.0M; investing −$48.0M (mostly parking proceeds into short-term investments + buying a corporate HQ); financing +$236.1M (issuance $219.8M + warrants $16.3M).
- Effectively no debt; deferred revenue trivial ($248K) — consistent with an almost non-existent recurring book.
- Total stockholders' equity ~$340M at Q1, ~98% of which is the cash pile; accumulated deficit growing (−$32.1M retained earnings at Q1).
Market reaction / what's priced in: The stock has de-rated from a 52-week high of $7.43 to ~$2.12 (2026-06-20), with the violent leg down catalyzed by the Jan-2026 Microsoft scandal (Lens 8/10). At ~$2.12 the stock trades at roughly its cash/book value (cash/share ~$1.66, book ~$1.72 per Feb-2026 web data ) — the market is now pricing the operating business at ~zero-to-slightly-negative, which is rational.
Lens 6 · Earnings Calls (sentiment trend)
No transcripts on disk (transcripts/ empty). From web: management's narrative is relentlessly forward-pointing and partnership-driven — "Super-Operator," NVIDIA/Jetson Thor, Microsoft AI Co-Innovation, "Southeast Asian expansion," "8–10% FY26 revenue growth, 15% loss reduction". The shift over time is from product-launch hype (Dex at GTC, Oct 2025) to damage control post-Hunterbrook (Jan 2026). Recurring phrases: "embodied AI," "RaaS," "data flywheel," "first-mover." What's conspicuously thin: hard unit economics, named paying RaaS customers with dollar values, and any path to operating breakeven. Tone management leans promotional — and the Microsoft episode shows that promotion crossed into alleged misrepresentation.
Lens 7 · Comps
Peers are early/loss-making physical-AI and service-robotics names. Multiples below are `` and approximate — point-in-time, 2026; treat as directional, not precise. RR's own multiple is the only point that matters:
| Company | Ticker | ~Mkt cap | EV/Sales | P/E | Note |
|---|
| Richtech Robotics | RR | ~$0.43–0.47B | ~85–90x | n/a (loss) | Revenue declining; EV/S collapses to ~36x only because ~60% of mkt cap is cash |
| Serve Robotics | SERV | mid-cap | premium P/S to peers | n/a (loss) | ~2,000 robots live w/ Uber Eats/DoorDash — real deployed scale vs RR's ~400 |
| Symbotic | SYMB/SYM | large-cap | lower P/S, near profitability | ~FY26 EPS +$0.50 est | Real revenue + Walmart contracts — the "what real scale looks like" anchor |
| Tennant | TNC | small/mid-cap | low single-digit EV/S (industrial) | profitable | Incumbent cleaning competitor to DUST-E; a sanity check on what a profitable robotics-adjacent business trades at |
| Bear Robotics | private | n/a | n/a | n/a | SoftBank-backed direct Matradee competitor; private |
Lens 8 · Stock-Price Catalysts (>5% moves, ~last 2 yrs)
RR is a high-beta retail/meme vehicle; the >5% moves are almost entirely narrative- and dilution-driven, not earnings-quality-driven:
- 2024-10-17: Walmart "20 robotic restaurants" announcement — hype spike (only 2 ever opened).
- 2025 (H2): Russell 2000/3000 index inclusion → passive flows + visibility; stock ran to a +625–852% trailing-12-month gain by Sept–Oct 2025; Dec 3 2025 +18.5% day on ~86.5M shares ("robotics policy buzz").
- 2025-10-28: Dex humanoid unveiled at GTC on NVIDIA Jetson Thor — AI-narrative pop.
- 2026-01-27: "Collaboration with Microsoft" PR → +30–40%, +~$370M mkt cap intraday.
- 2026-01-28: the next morning, RR announced a $38.7M dilutive private placement (8.5M shares) — i.e., it monetized the spike immediately.
- 2026-01-29: Hunterbrook Media (disclosed short RR, long a peer basket) publishes "Microsoft Denies Partnership"; Microsoft says "no commercial element" → stock −20%+.
- 2026-Feb–Jun: lawsuit overhang + dilution drift the stock from high-$2s toward ~$2.12.
Pattern the market actually reacts to: AI/partnership headlines and index/flow mechanics — NOT earnings. The reflexive loop is: hype a partnership → stock spikes → sell stock into the spike via ATM/placement → fundamentals never catch up. Earnings prints are nearly irrelevant to the tape; the catalysts are press releases and short reports. This is the defining behavioral fact of the name.
Phase C — Judge people & books
Lens 9 · Management
- Zhenwu (Wayne) Huang — Founder, CEO, Director (age 50). Founder since 2016; prior co-founder/CEO of Nanjing Rich Digital Technology (2003–07) and Richtech System Ltd.
- Zhenqiang (Michael) Huang — Co-founder, CFO, Director (age 47). Wayne's brother. The CEO and CFO being siblings, both founders, is a material governance concentration — finance and the top job are inside one family.
- Phil Zheng — COO (age 33). Adopted a Rule 10b5-1 plan 2025-05-25 to sell up to 200,000 Class B shares through 2025-12-31.
Skin in the game / control: The Huang brothers beneficially own ~66% of total voting power; Wayne alone holds ~52% via 30.3M super-voting Class A shares (10 votes/share). RR is an explicit "controlled company" under Nasdaq rules, exempting it from key independent-board requirements. Founders are deeply in control but their economic stake is concentrated in voting power, not in the diluting Class B that public holders own.
Capital-allocation history — poor: (1) Raised >$236M in FY25 financing against a business that loses money and shrank revenue; (2) used proceeds to buy a corporate HQ and triple G&A rather than to scale a proven unit economic; (3) the recurring move is issue equity into hype (3 ATMs in FY25 totaling ~$153M of the year's issuance, plus a $1.0B-capacity Sept ATM shelf, plus the Jan-2026 $38.7M placement). ROE/ROIC are deeply negative and getting worse.
Red flags (acute):
- Independent director Stephen Markscheid has been a defendant/consolidated-defendant in at least four separate securities/fraud matters in his capacity as a director of other China-linked issuers — ChinaCast Education (court found ChinaCast liable $65.8M; related Chancery judgment $183.3M for breach of fiduciary duty; settled Dec 2022), JinkoSolar (settled 2016), and China Integrated Energy/CBEH (two consolidated suits, settled 2015). He sits on six other public boards simultaneously, several SPACs. This is a serial-China-fraud-adjacent independent director on the audit-governance body of a company now itself accused of securities fraud.
- Founder/professional split: This is a founder-controlled company, which at this stage means promotional incentives and family control dominate; the "professional" overlay (CFO is the founder's brother; advisory board of ex-restaurant/banking names) does not provide independent ballast.
- The CEO is the named author of the Microsoft-collaboration statements now at the center of the 10b-5 suit (Lens 10).
Verdict on management: Promotional, control-entrenched, and a demonstrated willingness to issue stock into manufactured narrative. Not trustworthy as stewards of the cash on behalf of minority holders.
Lens 10 · Forensic Red Flags
This is the lens that decides the name. Multiple severe flags:
- MATERIAL WEAKNESS in revenue recognition & deferred revenue (auditor-flagged). The auditor's Critical Audit Matter states outright: "We found that a material weakness relating to its revenue recognition and deferred revenue". For a company whose entire bull thesis is "transition to recurring RaaS revenue," a material weakness in how it recognizes that exact revenue is disqualifying-grade. As an emerging-growth + smaller-reporting company it is exempt from SOX 404(b) auditor attestation, so internal-control assurance is minimal.
- Tiny, related-geography auditor. Auditor is Bush & Associates CPA LLC, Henderson, Nevada (PCAOB ID 6797), serving since 2023 — a micro-firm auditing a ~$450M-mkt-cap company headquartered in nearby Las Vegas, NV. Small-auditor + material weakness + China-CM supply chain is a classic forensic cluster.
- Intangibles issued for stock (second CAM). RR issued shares as consideration for "technology-related and other intangible assets," carried at $9.76M, with fair value resting on "highly judgmental assumptions". Non-cash, related-to-stock-price, highly subjective — a soft spot for inflated asset values and future impairment.
- SBC-flattered "adjusted" loss. ~$8.3M of the ~$8.4M Q1 net loss is stock-based comp. The cash loss looks small only because the real cost is dilution — the share count doubled YoY. Watch for "adjusted EBITDA"-style framing that hides the dilution.
- Revenue quality: the FY25 "growth" was one-time legacy hardware (management's own words), and recurring revenue fell; Q1 FY26 revenue then declined outright.
Regulatory & legal findings (required sub-section):
- SEC EDGAR EFTS (LR + AAER): No Litigation Releases or AAERs naming Richtech Robotics in 2021-06-21 → 2026-06-21. (No formal SEC enforcement — yet.)
- Securities class action (the headline): Multiple firms (Hagens Berman, Kuehn Law, Berger Montague, Bragar Eagel & Squire) filed/announced 10(b) / 20(a) / Rule 10b-5 class actions over the Microsoft claims; class period Jan 27–29, 2026; lead-plaintiff deadline Apr 3, 2026. Core allegation: RR's 2026-01-27 PR described a "hands-on collaboration… joint engineering effort" with Microsoft; Microsoft told Hunterbrook the engagement had "no commercial element" and was a standard, free AI Co-Innovation Lab program — and RR allegedly used the resulting +40% spike to price a $38.7M private placement the next morning.
- Insider exit into the event: former President Matthew Casella reportedly sold all his shares post-announcement. (Casella served as President until Dec 2025 per the 10-K.)
- 10-K Item 3 (company's own disclosure): one NY civil action (Index 517888/2025, filed 2026-06-02 [sic — 2025-06-02]) — breach of contract/warranty, fraud, and joint-venture liability; plaintiff seeks >$600K; RR filed a motion to dismiss, calls it meritless.
- Director litigation history: see Markscheid (Lens 9).
Net: This is one of the most red-flagged names a robotics deep-dive can surface — an auditor-declared material weakness in the exact revenue it's selling investors, a micro-auditor, intangibles-for-stock, a doubling share count, and an active securities-fraud class action over a partnership the counterparty publicly disowned. No material formal SEC enforcement to date, but the private-litigation and forensic picture is severe — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-06-21.
Phase D — Project & stress-test
Lens 11 · Forward Projection
RR is not an EPS-projection name — it loses money structurally and the share count is a moving target (ATM-driven). The honest model is cash-and-burn + sum-of-the-parts, not a P/E forward.
Base / Bull / Bear, fiscal years FY26–FY28 (FYE Sep 30) — all ``, inputs labeled:
- Revenue base: FY25 $5.05M; Q1 FY26 annualizes to ~$4.6M (run-rate from $1.147M × 4). Management guides "8–10% FY26 growth", which is not visible in the Q1 print.
- Bear FY26 ~$4.5M (continued −10% decline); Base FY26 ~$5.3M (flat-to-slightly-up if RaaS adds bookings); Bull FY26 ~$6.5M (RaaS + Dex shipments inflect). FY27/FY28 fan to $5–12M base/bull — still trivial.
- Opex: G&A run-rate ~$11–12M/qtr is SBC-loaded; cash G&A perhaps ~$3–4M/qtr. Cash operating burn ~$10–15M/yr ex-SBC.
- Cash runway: ~$272M cash (2025-12-31) ÷ ~$10–15M/yr cash burn = 15–25+ years of runway on the current cash alone. Solvency is a non-issue; the risk is value destruction and dilution, not bankruptcy.
- EPS: negative across all three years and all three scenarios; not a meaningful output. n/a — no positive EPS to project.
The number that actually matters — value floor: At ~$2.12, RR trades at ~1.2x its ~$1.72 book / ~1.28x its ~$1.66 cash-per-share. Downside is roughly bounded by net cash (~$1.6–1.7/share) unless the cash is burned or litigation/settlement erodes it; upside requires the market to re-pay a growth multiple on a business that is currently shrinking and legally tainted. Risk/reward from here is "limited downside to cash, but no credible catalyst to re-rate the operating business — and a live overhang that can take it below a naive cash value if sentiment breaks."
Forecast log: Per --watchlist rules, no forecast.ts create in this loop (and there is no committed EPS base case worth scoring — the defensible forecast is binary/structural, not an EPS line). If logged later, the scoreable claim would be: "RR FY26 revenue < $6M" (high confidence) and "RR closes 2026 below $3.00" (medium) — not committed here.
Lens 12 · Bull vs Bear
Bull case (steelmanned):
- ~$272M net cash, ~zero debt — a war chest ~60% of market cap; the equity is hard to break to zero and trades near cash.
- Real (if small) deployed footprint (~400 robots), a broad product line, NVIDIA Jetson Thor on Dex riding the physical-AI/humanoid narrative into 2026.
- RaaS mix shifting to recurring (RaaS +31% YoY in Q1 off a tiny base ); optional upside if Data Services lands a real foundation-model customer.
- Index membership (Russell 2000/3000) + heavy retail following → reflexive squeeze potential (short interest reached ~27% ).
- Management could, in principle, become a credible "AI-robotics holding company" by deploying the cash into M&A.
Bear case (2–3 permanent-impairment risks):
- The business doesn't work and is shrinking — revenue −42% from peak, Q1 −8.8% YoY, gross profit −47% YoY; no demonstrated path to operating leverage at this scale. The "growth story" is contradicted by its own financials.
- Governance + integrity break — auditor-declared material weakness in revenue recognition, micro-auditor, brothers controlling ~66% of votes, and an active 10(b)/10b-5 class action over a Microsoft "partnership" Microsoft denied. A settlement, restatement, or formal SEC interest would permanently impair trust (and could spend the cash).
- Serial dilution is the actual product — share count doubled YoY; a $1.0B-capacity ATM shelf is live. Even if the stock is "cheap to cash," management keeps issuing into strength, capping per-share value.
Pre-mortem (18 months out, thesis broke): Either (a) RR settled/paid the class action and/or restated revenue, the cash pile shrank, and the stock broke below cash on a confidence collapse; or (b) the meme/short-squeeze energy fully drained, index/retail flows reversed, Dex shipped to little revenue, and the stock bled toward true cash value (~$1.5–1.7) with no re-rate; or (c) management deployed the cash into a value-destructive acquisition.
Are multiples too high? Yes on the operating business (~85–90x declining sales). The only defensible valuation is "trades near cash," which means you're not paying for growth — you're betting the cash isn't squandered and a narrative re-rate happens. That's a trade, not an investment.
Contrarian view (what the market refuses to see — cuts both ways): Bulls refuse to see that the Microsoft episode wasn't a one-off — it's the operating model (hype → spike → issue stock). Bears refuse to see that, post-collapse to ~cash, the asymmetry has flipped: there's ~$1.6–1.7/share of cash under a ~$2.12 stock, so the downside is now somewhat protected even as the business remains worthless — making it a balance-sheet/event trade, not a short slam-dunk from here.
Lens 13 · Devil's Advocate (short-seller)
Dismantling the bull case:
- What structurally breaks the money machine? It never made money to begin with — interest income > product gross profit. The "machine" is capital raising, and that breaks the moment the AI/robotics narrative cools or a court/regulator constrains the promotion.
- Where is revenue concentrated, and what if it shifts? Revenue is so small (~$5M) that the loss of any single enterprise MSA (e.g., the "top-5 dealership group") is a double-digit-percent revenue hit; the >$600K NY contract suit alone is ~12% of revenue.
- Why is the moat weaker than bulls think? RR concedes it has no market-leadership and that a competitor (Avidbots) undercuts its scrubber by >$10K. Bear (SoftBank), Pudu (China, cheaper), Tennant (incumbent), and Tesla/Figure (humanoid capital) all out-resource it on the axes that matter.
- Most dangerous competitor bulls underestimate: Pudu/Bear on the commercial side (price + funding) and Tesla Optimus / Figure on Dex — RR's "humanoid" is a wheeled dual-arm cart with a Jetson; it is not competitive with well-capitalized humanoid programs.
- Worst capital-allocation / accounting moves: issuing $236M of stock into hype; intangibles-issued-for-shares; G&A tripling (incl. buying a HQ); a material weakness in revenue recognition; CEO/CFO being brothers with ~66% control.
- What must hold for today's price? That the cash isn't burned or litigated away, and that retail/narrative keeps the stock at a premium to cash. Both are fragile.
- If growth disappoints 20–30%? It already has (−42% from peak); a further leg means the stock converges to pure cash value (~$1.6–1.7) — ~20–25% downside from ~$2.12, more if litigation spooks holders.
- Single scenario that permanently impairs: an SEC enforcement action or restatement stemming from the revenue material weakness or the Microsoft claims — which would both destroy the narrative and potentially spend the cash on settlements/penalties.
Lens 14 · Management Questions (ordered by information value)
- The audit report cites a material weakness in revenue recognition and deferred revenue — what specifically failed, what is the remediation plan and timeline, and has any prior-period revenue been or will it be restated?
- Walk us through the Microsoft "AI Co-Innovation Labs" engagement precisely: was there ever any commercial or contractual element, who approved the 2026-01-27 "hands-on collaboration / joint engineering" language, and why was a $38.7M placement priced the next morning?
- Q1 FY26 revenue fell 8.8% YoY and is ~42% below the FY23 peak — reconcile that with the "8–10% FY26 growth" guidance and the "Super-Operator / 100,000 robots" mission.
- Of the ~$8.4M Q1 net loss, ~$8.3M was stock-based comp — what is the cash operating burn, and what is the multi-year dilution schedule given the $1.0B-capacity ATM shelf?
- You hold ~$272M cash earning more than your product gross profit — what is the explicit capital-allocation policy (buybacks at/below cash value? M&A? return of capital?), and what governs it given founder control?
- How many RaaS contracts are live, what is committed ARR and average contract value/term, and what is net revenue retention?
- The Walmart "20 locations" plan yielded 2 open locations — what actually happened, and what is the real status of the "top-5 dealership group" MSA in dollar terms?
- What are true RaaS-fleet unit economics: hardware cost per unit, monthly RaaS price, gross margin after depreciation, and payback period?
- Given a "controlled company" structure with the CEO and CFO as brothers holding ~66% of votes, what independent controls protect minority (Class B) holders?
- Why is a Las Vegas company of this market cap audited by a Henderson, NV micro-firm, and have you considered a national/Big-4-tier auditor as you scale?
- The $9.76M of intangibles issued for shares — what assets, what valuation method, and what is the impairment-test sensitivity?
- NVIDIA and Chinese contract manufacturers are single points of dependency — what is the second-source / tariff-mitigation plan, and is the NVIDIA relationship anything more than buying Jetson modules off the shelf?
- Independent director Stephen Markscheid has been a defendant in multiple securities-fraud matters at other issuers — what diligence did the board do, and is that appropriate for audit/governance oversight?
- What are the specific, measurable milestones and revenue expectations for Dex in 2026, and what happens to the thesis if it ships to negligible revenue?
- Under what circumstances would management stop issuing equity, and at what stock-price-to-cash ratio do buybacks become preferable to issuance?